Skip to main content

Bydureon 2 mg single-dose pen Images

Generic Name: exenatide

This medication has been identified as Bydureon 2 mg single-dose pen. It is supplied by AstraZeneca.

Bydureon is used in the treatment of Diabetes, Type 2 and belongs to the drug class incretin mimetics. Risk cannot be ruled out during pregnancy. Bydureon 2 mg single-dose pen is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Bydureon 2 mg single-dose pen medicine

Bydureon

Generic Name
exenatide
Strength
2 mg single-dose pen
Availability
Prescription only
Drug Class
Incretin mimetics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
AstraZeneca
National Drug Code (NDC)
00310-6530 (Discontinued)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.